Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung Cancer

15 Jan 2007

Abstract excerpt

PURPOSE: Analysis of molecular genetic markers in biological fluids has been proposed as a powerful tool for cancer diagnosis. We have characterized in detail the genetic signatures in primary non-small cell lung cancer, which provided potential diagnostic biomarkers for lung cancer. The aim of this study was to determine whether the genetic changes can be used as markers in sputum specimen for the early...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomic variations and chromosomal abnormalities
Share to Lung Cancer Research Studies
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17255269
DOI: 10.1158/1078-0432.ccr-06-1593

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung CancerPMID 17255269Read ↗

DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateSemantic proximity Read ↗

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approachSemantic proximity Read ↗

Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case–control study for risk assessmentSemantic proximity Read ↗

Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokersSemantic proximity Read ↗

Subtyping Lung Cancer Using DNA Methylation in Liquid BiopsiesSemantic proximity Read ↗

The Detection of Chromosomal Aneusomy by Fluorescence In situ Hybridization in Sputum Predicts Lung Cancer IncidenceSemantic proximity Read ↗

DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNASemantic proximity Read ↗

Molecular Alterations in Spontaneous Sputum of Cancer-Free Heavy Smokers: Results from a Large Screening ProgramSemantic proximity Read ↗

Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer.Semantic proximity Read ↗

Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer.Semantic proximity Read ↗

Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lungSemantic proximity Read ↗

Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer RiskSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.